Please login to the form below

Not currently logged in
Email:
Password:

Cluster headaches

This page shows the latest Cluster headaches news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly scores positive phase 3 results for Emgality in treatment resistant migraine

Eli Lilly scores positive phase 3 results for Emgality in treatment resistant migraine

Since then, the drug also claimed the first FDA approval in the class for cluster headaches earlier this year.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics